|
|
List of countries which follow
WHO-GMP guidelines for registration of products.
|
Bulgaria* |
Iraq* |
Romania* |
|
Burkina Faso* |
Indonesia* |
Russia* |
|
Bhutan* |
Ivory
Coast* |
South
Africa* |
|
Bolivia* |
Jamaica* |
Senegal* |
|
Botswana* |
Jordan* |
Sri Lanka* |
|
Brazil* |
Kenya |
Sudan* |
|
Cambodia* |
Lebanon* |
Suriname* |
|
Chile* 33 |
Madgascar* |
Syria* |
|
Costa Rica* |
Malawi* |
Trinidad &
Tobago* |
|
Cyprus* |
Mexico** |
Taiwan** |
|
Cameroon* |
Maldives* |
Thailand* |
|
Dominic Republic* |
Mongolia* |
Tanzania |
| Ecuador* |
Malaysia* |
Turkey* |
|
Ethiopia* |
Mali* |
Uganda* |
|
Egypt* 40 |
Mauritius* |
Ukraine* |
|
Fiji** 41 |
Mozambique* |
Uzbekistan* |
|
Georgia* |
Myanmar* |
Venezuela* |
|
Ghana* |
Nepal* |
Vietnam* |
|
Guatemala* |
Nigeria* |
Yemen* |
|
Guinea* |
Niger* |
Zambia* |
| Haiti* |
Oman* |
Zimbabwe* |
| Honduras* |
Philippines* |
|
|
Hong Kong* |
Pakistan* |
|
|
Holland* |
Panama* |
|
| Iran* |
Peru* |
|
* Dossiers available
** Dossiers Under
preparation |
|
|
WHO-GMP Approved manufacturing facilities
|
 |
|
WHO-GMP
Approved manufacturing facilities for Oncology, General
tablets and cephalosporin.
|
| |
|
Markets
|
 |
|
Regulated Markets
(USA, EUROPE)
Non-Regulated
(SOUTH EAST, ASIA, AFRICA, LATIN
AMERICA, CIS ETC)
|
|
|
